RIL
ORIC icon

Rothschild Investment LLC’s Oric Pharmaceuticals ORIC Stock Holding History

Rothschild Investment LLC’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36K Buy
126
+49
+64% +$444 ﹤0.01% 2926
2026
Q1 		$976 Buy
77
+32
+71% +$363 ﹤0.01% 2881
2025
Q4 		$368 Hold
45
– – ﹤0.01% 3006
2025
Q3 		$540 Sell
45
-45
-50% -$473 ﹤0.01% 2809
2025
Q2 		$914 Sell
90
-90
-50% -$604 ﹤0.01% 2517
2025
Q1 		$1K Buy
180
+85
+89% +$743 ﹤0.01% 2338
2024
Q4 		$767 Sell
95
-20
-17% -$184 ﹤0.01% 2369
2024
Q3 		$1.18K Buy
115
+95
+475% +$939 ﹤0.01% 2047
2024
Q2 		$141 Buy
+20
New +$179 ﹤0.01% 2602

Other funds holding ORIC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Rothschild Investment LLC's ORIC Position: Q2 2026 in Review

Rothschild Investment LLC increased its Oric Pharmaceuticals (ORIC) stake by 64% in Q2 2026, buying an estimated $444 and bringing the position to 126 shares worth $1.36K. The position accounts for ﹤0.01% of the portfolio, ranked #2926.

Rothschild Investment LLC first reported a position in ORIC in Q2 2024 and has held it in 9 quarters since. 39 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Rothschild Investment LLC held 126 shares of Oric Pharmaceuticals worth $1.36K as of Q2 2026.
  • Rothschild Investment LLC bought 49 Oric Pharmaceuticals shares in Q2 2026, an estimated $444.
  • Oric Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2926 holding.
  • Rothschild Investment LLC first reported a position in Oric Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • 39 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.